Tscan Therapeutics, Inc.

This study screens up to 1,150 adults with advanced solid tumors (like head and neck, cervical, or lung cancer) to check their genetic markers and tumor features. The goal is to find who might qualify for future experimental T-cell therapies that target specific cancer antigens. …